| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $0 | -100.0% | -100.0% |
| SG&A Expense | $17K | +0.0% | -0.7% |
| Operating Income | -$67K | +45.2% | +30.3% |
| Interest Expense | $14K | -42.9% | +22.2% |
| Pre-tax Income | -$79K | +45.5% | +45.4% |
| Income Tax | $0 | — | — |
| Net Income | -$79K | +45.5% | +45.4% |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6K | +14.2% | — |
| Current Assets | $6K | +14.2% | -95.8% |
| Total Assets | $6K | +14.2% | -95.8% |
| Current Liabilities | $3.5M | +2.4% | +14.1% |
| Total Liabilities | $3.5M | +2.4% | +14.1% |
| Stockholders' Equity | -$3.5M | -2.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$123K | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $110K | — | — |
| -19.9% |